Systematic-Review-Drug-Efficiency-Dissertation-Sample-Work-Tutors-India
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b). Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
percentage predicted FEV1, total lung capacity (TLC) and the percentage predicted TLC, DLCO and the percentage predicted DLCO, DLCO/VA from baseline to week 48; the change in ABGs including PaCO2, © 2017-2018 All Rights Reserved, No part of this document should be modified/used without prior consent Tutors India - Your trusted mentor since 2001 www.tutorindia.com I UK # +44-1143520021, info@tutorsindia.com Page 92 of 172
- Page 57 and 58: should be undergone to reveal wheth
- Page 59 and 60: CHAPTER III: RESEARCH METHODOLOGY T
- Page 61 and 62: 3.2 Meta-analysis of Randomised Con
- Page 63 and 64: 3.4.1 Inclusion criteria The inclus
- Page 65 and 66: 3.6.1 Dichotomous Comparisons The v
- Page 67 and 68: CHAPTER IV: RESULTS 4.1 Introductio
- Page 69 and 70: Following are the questions of the
- Page 71: Study number Table 2- CASP assessme
- Page 75: primary objective is to examined wh
- Page 79: to NAC inhaled inhaled NAC and oral
- Page 82: S. no Author; Year 1 Behr et al 7 C
- Page 86: pirfenidone combined with highdose
- Page 90: or temporary cessation of pirfenido
- Page 93: 4.5 Patient characteristics, interv
- Page 97: oom air 3 Sakamoto et al 15 Effecti
- Page 101 and 102: Of the studies considered for the s
- Page 103: 4.6 Evaluation of Efficacy of Prife
- Page 107: change in the lowest SPO2 during th
- Page 113: (DLco) of almost 43% of the predict
- Page 116 and 117: 4.7 Assessment of likelihood of com
- Page 118 and 119: espectively. However, one study by
- Page 120 and 121: the combined effects of these drugs
- Page 122 and 123: Pirfenidone, which is a proven ther
- Page 124 and 125: with respect to background factors
- Page 126 and 127: patient in the intervention group a
- Page 128 and 129: and N-acetylcysteine when combined
- Page 130 and 131: References Abehsera, M., Valeyre, D
- Page 132 and 133: from: http://www.ncbi.nlm.nih.gov/p
- Page 134 and 135: worsening of idiopathic pulmonary f
- Page 136 and 137: (6). pp. 515-20. Available from: ht
- Page 138 and 139: http://www.ncbi.nlm.nih.gov/pubmed/
- Page 140 and 141: Hunninghake, G.W., Colby, T. V., Eg
- Page 142 and 143: Diaz de Leon, A., Cronkhite, J.T.,
- Page 144 and 145: predictors of a diagnosis of idiopa
- Page 146 and 147: ole remains uncertain as anti-inter
- Page 148 and 149: (2007). Occupational exposure and s
- Page 150 and 151: Hillerdal, G., Nöu, E., Osterman,
- Page 152 and 153: Increasing Global Mortality from Id
- Page 154 and 155: pulmonary fibrosis. The New England
- Page 156 and 157: Kim, D.S. (2006). Classification an
percentage<br />
predicted<br />
FEV1, total<br />
lung capacity<br />
(TLC) and the<br />
percentage<br />
predicted<br />
TLC, DLCO<br />
and the<br />
percentage<br />
predicted<br />
DLCO,<br />
DLCO/VA<br />
from baseline<br />
to week 48;<br />
the change in<br />
ABGs<br />
including<br />
PaCO2,<br />
© 2017-2018 All Rights Reserved, No part of this document should be modified/used without prior consent<br />
<strong>Tutors</strong> <strong>India</strong> - Your trusted mentor since 2001<br />
www.tutorindia.com I UK # +44-1143520021, info@tutorsindia.com<br />
Page 92 of 172
Change language